How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 180 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
The page below is a sample from the LabCE course Tracking Antibiotic-Resistant Tuberculosis. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Tracking Antibiotic-Resistant Tuberculosis (online CE course)

Abubakar I, Zignol M, Falzon D, et al. Drug-resistant tuberculosis: time for visionary political leadership [The Lancet Infectious Diseases Web site]. June 2013;13(6):529-539. Accessed May 12, 2022.
Ahuja SD, Ashkin D, Avendano M, et al. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: An individual patient data meta-analysis of 9153 patients. PLOS Med. August 28, 2012; 9(8) e1001300. Accessed May 12, 2022.
Barrera L. The basics of clinical bacteriology. In: Palomino JC, Leao SC, Ritacco V, eds. Tuberculosis 2007:From basic science to patient care. 1st ed. San Paulo: 93-112. Accessed May 12, 2022.
Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Eng J Med. September 9, 2010; 363:1005-1015. Accessed May 12, 2022.
Brazier B, McShane H. Towards new TB vaccines. Semin Immunopathol. 2020;42(3):315-331. doi:10.1007/s00281-020-00794-0
Cegielski P, Nunn P, Kurbatova, EV, et al. Challenges and controversies in defining totally drug-resistant tuberculosis. Centers for Disease Control and Prevention [Web site]. November 2012;18(11). Accessed May 12, 2022.
Centers for Disease Control and Prevention (CDC). Drug-Resistant TB. CDC website. Oct. 2021. Accessed May 11, 2022.
Centers for Disease Control and Prevention (CDC) Fact Sheets 2016. BCG vaccine. Accessed May 12, 2022.
Centers for Disease Control and Prevention (CDC) Fact Sheets 2016. Interferon-gamma release assays (IGRAs)- blood tests for TB infection. MMWR. 2010;59 (No.RR-5). Accessed May 12, 2022.
Centers for Disease Control and Prevention (CDC) Fact Sheets 2020. The Costly Burden of Drug-Resistant TB in the U.S. 2020. Accessed May 12, 2022.
Centers for Disease Control and Prevention (CDC). Trends in tuberculosis—United States 2021. Morbity and Mortality Weekly Report (MMWR). March 25, 2022;71(12):441-446. Accessed May 12, 2022.
Filia A, Ciarrocchi G, Belfiglio R, et al. Tuberculosis in kindergarten and primary school, Italy, 2008-2009 [dispatch]. Centers for Disease Control and Prevention [Web site]. March 2011;17(3). Accessed May 12, 2022.
Fitzgerald D, Haas DW. Mycobacterium tuberculosis. In: Mandel, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Philadelphia, PA: Elsevier Inc; Updated 2020.
Garfein RS, Laniado-Laborin R, Rodwell TC, et al. Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico [research]. Centers for Disease Control and Prevention [Web site]. May 2010;16(5). Accessed May 12, 2022.
Global tuberculosis report 2019. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO. Accessed May 12, 2022.
Lee SH. Tuberculosis Infection and Latent Tuberculosis. Tuberc Respir Dis (Seoul). 2016;79(4):201-206. doi:10.4046/trd.2016.79.4.201
Lin S-Y, Probert W, et al. Rapid detection of isoniazid and rifampin resistance mutations in Mycobacterium tuberculosis complex from cultures or smear-positive sputa by use of molecular beacons. J Clin Microbiol. September 2004;42(9):4204. Accessed May 12, 2022.
McKinnon J. Budget cuts hit TB clinics at the border. Associated Press, California Health Report. April 2, 2012.
Migliori G, Ortmann J, Girardi E, et al. Extensively drug-resistant tuberculosis, Italy and Germany [letter]. Emerg Infect Dis. Centers for Disease Control and Prevention [Web site]. May 2007;13(5). Accessed May 12, 2022.
Parrish NM, Carroll KC. Role of the clinical mycobacteriology laboratory in diagnosis and management of tuberculosis in low -prevalence settings. Jour Clin Microbiol. March 2011;49(3): 772-776. Accessed May 12, 2022. http:="" www.ncbi.nlm.nih.="" gov="" pmc="" articles="" pmc3067741="" ?="" report="reader.
Pfyffer GE. Mycobacterium: General characteristics, laboratory detection, and staining procedures. In: Carroll KC, Pfaller, MA. Manual of Clinical Microbiology, 12th ed. Washington, DC: ASM Press; 2019.
Phillips L. Infectious disease: TB’s revenge. Nature. January 2, 2013;493:14-16. Accessed May 12, 2022.
Pinon M, Scolfaro C, Bignamini E, et al. Two pediatric cases of multidrug-resistant tuberculosis treated with linezolid and moxifloxacin. Pediatrics. November 1, 2010;126(5):e1253-e1256. Accessed May 12, 2022.
Richter E, Brown-Elliott BA, Wallace Jr. RJ, et al. Mycobacterium: Laboratory characteristics of slowly growing mycobacteria. In: Carroll KC, Pfaller MA. Manual of Clinical Microbiology, 12th ed. Washington, DC: ASM Press; 2019.
Russell DG, Cardona PJ, Kim MJ, et al. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol. September 2009;10(9):943-948. Accessed May 12, 2022.
StopTBPartnership. The Paradigm Shift 2018-2022. 2015. Accessed May 14, 2022.
TuBerculosis Vaccine Initiative (TBVI). What we do: Pipeline of vaccines. 2022. Accessed May 14, 2022.
Udwadia ZF. MDR, XDR, TDR tuberculosis: ominous progression. Thorax [serial online]. 2012; 67(4). Accessed May 12, 2022.
Udwadia ZF, Amale RA, Ajbani KK, et al. Totally drug-resistant tuberculosis in India [correspondence]. Clin Infect Dis. 2012; 54(4):579-581. Accessed May 12, 2022.
Udwadia ZF. Totally drug-resistant tuberculosis in India: Who let the djinn out? [editorial]. Respirology 2012;17:741-742. DOI: 10.1111/j.1440-1843.2012.02192.x
United Nations. Sustainable Development Goals. website. September, 2018. Accessed May 14, 2022.
Woods GL, Lin S-Y G, Desmond EP. Susceptibility test methods: Mycobacteria, Nocardia, and other Actinomycetes. In: In: Carroll KC, Pfaller MA, Manual of Clinical Microbiology, 12th ed. Washington, DC: ASM Press; 2019.
World Health Organization (WHO). Estimated incidence of MDR/RR Tuberculosis (TB) in 2019. WHO website, March 2021. Accessed May 13, 2022.
World Health Organization (WHO). Global Tuberculosis Report 2021, pg 28. 2021. Accessed May 11. 2022.
World Health Organization (WHO). Tuberculosis: Drug-resistant tuberculosis (XDR-TB). Jan. 2018. Accessed May 12, 2022.
World Health Organization (WHO). Tuberculosis. World Health Organization website. Oct. 14, 2021. Accessed May 12, 2022.